9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Crescent Biopharma, Inc. Annual Meeting Vote Results - June 2, 2026
Reports First Quarter 2026 Financial Results and Recent Business Highlights
Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Crescent Biopharma Partners with Kelun-Biotech, Raises $185M for Therapeutics, Investor Presentation
Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Material Contracts, Completing Asset Acquisition or Sale, Financial Results, Material Modifications to Rights of Security Holders, Changing the Company's Accountant, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Amendment to Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics, Ch
Stockholders Approve Proposed Merger and All Related Proposals
Amended Quarterly Report
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload